Short Synthesis of Dopamine Agonist Rotigotine
Synthesis · 16.07.2024 · 56 (14) · 2234-2238
DOI: 10.1055/a-2235-5080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 16.07.2024. Verfasst von Srivari Chandrasekhar und 3 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, University Grants Commission, Science and Engineering Research Board.
Abstract (Originalsprache)
A practical and short synthesis of FDA approved drug, Rotigotine, is achieved in two steps from 5-methoxy-2-tetralone, which in turn was synthesised by [4+2] cycloaddition of the in situ generated methoxyaryne from its precursor aryl triflate with benzyloxybutadiene or from 4-methoxyindanone via ring expansion using trimethylsilyldiazomethane.
Förderung
- Council of Scientific and Industrial Research
- University Grants Commission
- Science and Engineering Research Board
Zitieren
APA
Chandrasekhar, S., Shekhar, C., Karmakar, S., & Mainkar, P. S. (2024). Short Synthesis of Dopamine Agonist Rotigotine. Synthesis, 56(14), 2234-2238. https://doi.org/10.1055/a-2235-5080
Vancouver
Chandrasekhar S, Shekhar C, Karmakar S, Mainkar PS. Short Synthesis of Dopamine Agonist Rotigotine. Synthesis. 2024;56(14):2234-2238. doi:10.1055/a-2235-5080
BibTeX
@article{Chandrasekhar2024,
author = {Chandrasekhar, Srivari and Shekhar, Chandra and Karmakar, Santanu and Mainkar, Prathama S.},
title = {Short Synthesis of Dopamine Agonist Rotigotine},
journal = {Synthesis},
year = {2024},
volume = {56},
number = {14},
pages = {2234--2238},
doi = {10.1055/a-2235-5080}
}
EUVIMED